Crossmark

Influence of formulation and route of administration on ketamine’s safety and tolerability: systematic review

Published Online: 2020-11-18

Published Print: 2021-05

Authors

Glue, Paul https://orcid.org/0000-0002-7305-2800
Russell, Bruce

Medlicott, Natalie J.
License Information

Text and Data Mining valid from 2020-11-18

Version of Record valid from 2020-11-18
More Information

Article History

Received: 20 July 2020

Accepted: 13 November 2020

First Online: 18 November 2020

Compliance with ethical standards

:

: Drs Glue and Medlicott have a contract with Douglas Pharmaceuticals to develop novel ketamine formulations.

Document is current